Implementing a medication safety and poison prevention program at a senior center [0.03%]
在老年活动中心实施药物安全和预防中毒项目
Jennifer A Gershman
Jennifer A Gershman
The Institute for Safe Medication Practices encourages pharmacists to assist in preventing medication misuse. The purpose of this article is to discuss a medication-safety education session conducted by a pharmacy professor, the faculty adv...
Dominick Trombetta,Kathleen Garrett,Marissa Harrison
Dominick Trombetta
New-onset urinary retention can typically be explained by the use of the routine normally suspected medications (e.g., anticholinergics, antihistamines). However, selective serotonin-reuptake inhibitors are not typically presumed as the cau...
2013-2014 ASCP President Jeffrey C. Delafuente: a passion for pharmacy [0.03%]
2013-2014年ACSP主席Jeffrey C. Delafuente ：热诚的药学实践
Marlene Z Bloom
Marlene Z Bloom
Jeffrey C. Delafuente, MS, FCCP, FASCP, associate dean for academic affairs and professor of pharmacotherapy, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, will assume the office of 2013-2014 president of the Amer...
Caren McHenry Martin
Caren McHenry Martin
Pharmaceutical care of the hospice patient offers unique challenges in the management of pain and other symptoms. Lessons learned in providing hospice care can be used in the care of nonterminal patients as well to optimize patient-specific...
Katherine S McMichael,Katie Adams,Ericka L Breden Crouse
Katherine S McMichael
This case describes a 76-year-old African-American female with a history of depression, breast cancer, and hypothyroidism admitted to the inpatient geriatric psychiatry unit for an electroconvulsive therapy (ECT) evaluation. She had one pre...
Evaluating the potential benefits of metformin in patients with cardiovascular disease and heart failure [0.03%]
评估二甲双胍在心血管疾病和心力衰竭患者中的潜在益处
Daryn K Norwood,Allison A Chilipko,Shril M Amin et al.
Daryn K Norwood et al.
Objective: To examine the safety and potential benefits of metformin in diabetic patients with cardiovascular (CV) disease and heart failure (HF). Data so...
William Simonson,Rachel Novak,Trevor Jennewine
William Simonson
Objective: To determine requirements for medication monitoring in assisted living in the United States. Data sources: Comprehensive lis...
Reassessment of the prevalence, clinical characteristics, and pharmacologic treatment of nursing facility residents with Parkinson's disease [0.03%]
帕金森病患者的患病率、临床特征和药理治疗的再评估：一项关于疗养院居民的研究
Barbara J Zarowitz,Terrence O&#x;Shea
Barbara J Zarowitz
Objectives: The purpose of this investigation was to evaluate changes in the prevalence, clinical characteristics, and treatment patterns in nursing facility patients with Parkinson's disease (PD) from 2005 to 2010 and to...
Jeannette Y Wick
Jeannette Y Wick
Patients frequently misunderstand or cannot apply health information they receive from health professionals. Certain populations-particularly individuals with limited English skills or limited education-pose an additional challenge. The ave...
Jeannette Y Wick
Jeannette Y Wick
After more than 50 years of experience with benzodiazepines, the American health care system has a love-hate relationship with them. In 1955, Hoffmann-La Roche chemist Leo Sternbach serendipitously identified the first benzodiazepine, chlor...